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Canine Heartworm Disease 
Donna M. Rizzo, DVM * 
Wendy A. Ware, DVM ** 
Introduction 
Canine heartworm disease is a very complex 
multi systemic disorder. The primary lesions 
involve the cardiac and pulmonary systems; 
however, it is not unusual for the hepatic, renal 
or even nervous systems to be involved. Since 
1850, when heartworm disease was first de-
scribed, it has become a major concern in canine 
medicine. 
Distribution and Incidence 
The incidence of canine heartworm disease 
has steadily increased through the years. Todax.-
there are enzootic foci on nearly every conti-
nent. Originally a disease of warm coastal 
regions, unrestricted movement of infected dogs 
is held responsible for the spread ofthe disease 
to more temperate climates. In the United 
States there are now four enzootic regions. The 
first region extends along the Atlantic and 
coastal area, from Massachusetts to east Texas. 
This area includes the states with the highest 
prevalence of infection: Louisiana, Mississippi, 
Alabama, and Florida. At one time, infection 
rates in these states ranged from thirty to 
greater than fifty percent of the animals tested.' 
Preventative programs have resulted in a de-
cline ofthese numbers in recent years. Another 
enzootic focus engulfs the large number of states 
within the Mississippi River Valley, including 
Tennessee and Arkansas and extending north 
through Kentucky, Illinois . Indiana, Ohio. 
Missouri, Iowa, Minnesota, Wisconsin and 
Michigan. In another five to ten years, it is 
expected that this focus will have moved to 
include many of the states to its west. N atu-
rally acquired infections have already been 
reported in Nebraska, Kansas, and Colorado 
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Hawaii can be included in the well estab-
lished enzootic regions of the united States, 
and a relatively new focus in northern Califor-
nia has emerged since the beginning of the 
1970's. 
Etiopathogenesis 
Heartworm disease is the result of infection 
with the nematode Dirofilaria immitis. The 
adult worm lives within the right ventricle of 
the heart and pulmonary arteries. D. immitis is 
the longest oft"\le Dirofilaria genus. The adult 
female can reach lengths of 250-310mm. The 
smaller male measures 120-200mm. The fe-
male is viviparous, releasing microfilariae into 
the host's circulation. The parasite requires an 
intermediate host to pick up the microfilariae 
from the bloodstream and over sixty species of 
mosquitoes are capable of acting as this inter-
mediate host. The mosquito appears to be the 
only arthropod capable of supporting growth of 
the microfilariae. Research attempts to infect 
other arthropods, including the flea , have been 
unsuccessful. 2 The mosquito ingests the mi-
crofilariae with its blood meal. By day thirteen, 
the microfilariae have molted twice and devel-
oped into the infective third stage larvae. The 
larvae migrate to the proboscis and cephalic 
spaces ofthe mosquito, and are now prepared to 
infect the host. 
Canines, both wild and domestic, appear to 
be the definitive hosts of the heartworm. Inci-
dental necropsy findings have revealed adult 
worms in a large number of other mammals, 
including man. However, these infections are 
rarely patent, and usually consist of a single 
adult worm or a few infertile worms in a loca-
tion outside of the heart. Microfilariae positive 
infections have been documented in the domes-
tic cat, fox, sea lion, and ferret.! None of these 
animals represent a serious concern as a reser-
voir host. Among the domestic canines, there is 
no evidence of a breed or sex predilection. Length 
of hair coat is not important either. Statistics 
have shown that the deciding factor is depend-
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ent only on exposure risk. Outdoor and working 
dogs have a 3-6 times greater infection rate 
than the household pet.2 
The host becomes infected when an infective 
mosquito, acting as the vector, deposits the 
third stage larvae onto the skin ofthe host. The 
larvae later enter the host through the wound 
created by the mosquito. They remain in the 
subcutaneous tissue near the site of entry for 
the first 21 days . After molting into the fourth 
larval stage, they migrate through the abdo-
men and thorax of the host . Around day 70-80, 
the last molt occurs; this is the time when the 
first worms have reached the heart. By day 90-
120 all of the immature worms have reached 
their destination. Only about 40 percent ofthe 
larvae entering the host actually develop into 
adults. 1 Maturation and patency usually de-
velop 5-7 months after infection. 
Clinical Presentations 
The majority of heartworm cases presented 
to a veterinarian are picked up by routine 
diagnostic testing. In these animals, the dis-
ease is mild and clinical signs are often absent. 
In animals with heavy worm burdens or more 
advanced disease, the clinical signs are usually 
explained by the pathological changes within 
the cardiovascular system of the lungs. The 
presence of the adult nematode within the 
pulmonary arterial system results in an in-
tense inflammatory reaction of intimal prolif-
eration. This response is unique to heartworm 
disease. The proliferative growth varies from 
papillary extensions to luxurious folding of the 
intima. Older lesions become more scarred and 
cobblestone in appearance. The results of the 
lesions are restricted vessel lumens and thick-
ened walls. Fibrosis of both the intima and the 
media is more pronounced in the smaller arter-
ies, and complete obstruction can occur. In 
advanced disease, the sum total ofthese changes 
causes a dramatic decrease in the cross-sec-
tional area of the pulmonary arterial system 
and pulmonary hypertension. Dilation and 
hypertrophy of the right ventricle results from 
the pressure overload. Clinical signs become 
apparent as these cardiovascular changes prog-
ress. 
Animals may present initially with a gen-
era I loss of condition and a dry, harsh hair coat 
as a result of the metabolic stress. Chronic 
cough and hemoptysis are also common com-
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plaints. Auscultation is often normal; although 
an accentuated S2 and/or soft systolic murmur 
may be heard. Friction rubs may occasionally 
be present due to pleural adhesions caused by 
peripheral pulmonary hemorrhage. Mucous 
membranes may be pale due to both a depres-
sion anemia and perfusion deficiencies. As the 
severity of the disease condition progresses, 
cardiac insufficiency becomes evident. The 
animal becomes exercise intolerant and may 
experience syncope, tachypnea, and tachycar-
dia. Auscultation at this point may reveal a 
systolic murmur associated with both the pul-
monary and tricuspid valves . Worm-induced 
turbulence and dilation ofthe valvular annulus 
are believed to be responsible for the murmur. 
Severely diseased animals may present with 
signs of right-sided congestive heart failure : 
hepatomegaly, ascites, and a jugular pulse. As 
left-ventricular output drops from the low vol-
ume of blood passing through the hypertensive 
pulmonary system, the femoral pulse becomes 
weak. In very severe cases, peripheral cooling 
and extremity edema may be evident. These 
latter two signs are extremely poor prognostic 
indicators. 
Diagnosis 
The release of microfilariae into the infected 
host's circulation should make the diagnosis of 
heartworm infection straightforward. Unfor-
tunately, the picture is complicated by many 
other variables. First, 10-67% of infected ani-
mals do not have any circulating microfilaria.3 
These cases are referred to as occult infections. 
The classical occult presentation is the result of 
microfilarial trapping within the pulmonary 
capillary system by antibody and leukocytes. 
Absence of circulating microfilariae also occurs 
with prepatent, unisex, and infertile infections. 
Second, the presence of microfilariae is not 
always indicative of adult D. immitis infection. 
A documented 4.5% of microfilariae positive 
animals have no adult worms.4 After natural 
mortality (approximately seven years) or adul-
ticide treatment, microfilariae can remain in 
the bloodstream for up to 2 112 years. I Microfi-
lariae can also be transferred to uninfected 
animals by blood transfusion or placental trans-
fer. Lastly, although D.immitis is the only 
filarial parasite which results in clinically 
apparent disease in the dog, another parasite, 
Dipetalonema reconditum. also produces circu-
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lating microfilariae. Endemic to the same re-
gions as the heartworm, D. reconditum uses
the flea as its vector and lives within the subcu-
taneous tissue of its host.
Because of the enormous number of vari-
ables involved in heartworm infected animals,
diagnostic tests have been developed for both
microfilariae detection and serological evalu-
ations. Each test available has appropriate
applications, and associated advantages and
disadvantages.
Microfilariae Detection
These tests are the simplest and the least
expensive available. It is important to be aware
ofthe following characteristics ofmicrofilariae:
*microfilariae are not present until
5-6mo post infection
*the numbers of microfilariae
present do not correlate with the number of
adult worms present
*the numbers of microfilariae in any
one host show both seasonal and daily
cyclicity. Increased numbers are present
during the spring and summer, and in the
late afternoons and evenings
*some infected hosts show no circu-
lating microfilariae
*the microfilariae ofD.immitis must
be differentiated from those ofD.reconditum.
Wet mount: The technique of using a drop of
peripheral blood on a glass slide and observing
under a microscope is only dependable in infec-
tions with a high number of microfilariae. It
does not allow the assessment of the morphol-
ogy ofthe microfilariae, but can give a good idea
ofthe motility involved. This should not be used
as the sole means of diagnosing heartworm
infection.
Microcapillary tube: This method makes use
of a sample of blood within a microhematocrit
tube. Once again, microfilariae numbers must
be high, and assessment of morphology is not
possible. The tube is viewed under the micro-
scope, focusing up and down in the region above
the buffy coat. Dipetalonema microfilariae tend
to migrate well up into the plasma; Dirofilaria
tends to remain just above the buffy coat. This
test is useful as a screeningmeasure ifthe blood
has been drawn for other tests, but should not
be relied on for a diagnosis.
80
Concentration techniques: The most com-
monly used tests in this category are the filter
tests and the modified Knott's test. Concentra-
tion methods are 10-15% more sensitive than
the previous exams, and 50-90% more accu-
rate.3,4 These are the most frequently used
tests in veterinary clinics today. They are very
useful in routine yearly exams before beginning
a prevention program, as well as for the initial
exam of a suspected heartworm diseased ani-
mal.
The filter tests make use of a 1 ml sample of
whole or EDTA blood. This sample is placed in
9 ml ofa lysing solution; the lysed sample is run
through a filter chamber, and flushed with 10
ml of water. Depending upon the set pur-
chased, a dye may be used on the filter after it
has been placed on a glass slide. The sample is
read using a microscope. To avoid false posi-
tives, care must be taken not to contaminate the
lysing solutions with microfilariae positive
blood, and chambers should be cleaned well
between uses. False negatives can OCcur if
improper filters are used.
The modified Knott's test is the best for
examining the morphology ofthe microfilariae.
Although it requires a longer period of time,
sensitivity is equal to that ofthe filter tests and
it is less expensive. One ml of whole blood is
mixed with 9ml of2% formalin and centrifuged
for 5-8 minutes. The supernatant is discarded
and the sediment is stained with methylene
blue and viewed microscopically. Adequate
centrifugation is essential to prevent the loss of
the microfilariae with the supernatant.
Serological testing
Serological exams were developed to iden-
tify the occult heartworm infections. They can
be extremely helpful ifused properly and in the
correct situations. The accuracy and sensitiv-
ity of detecting infection varies greatly among
the different tests available. The results are
not absolute and should be used in conjunction
with history, clinical signs, and other diagnos-
tic aids. These tests are generally more expen-
sive and involved than the microfilariae detec-
tion tests, and are most useful following a nega-
tive microfilariae detection test on a suspect
animal.
Indirect Fluorescent Antibody: (e.g. Track
XIR) This test detects circulating host antibody
to the nlicrofilarial cuticular antigen. It is
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useful in detecting the true occult infections. It
will not detect infections where microfilaria
were never produced, as occurs with single sex,
prepatent, and single worm infections. Eighty-
five to ninety percent of the immunological
occult infections are positive by this test.4 The
exam is an involved procedure, and not offered
in most labs.
Enzyme-linked ImmunosorbantAssays: Two
different types of ELISA tests have been cre-
ated to assist in the diagnoses of heartworm
infection. The predictive value ofeach of these
is extremely different, so they will be discussed
separately.
The first ELISA applied towards diagnosis
detected circulating antibody to the adult Di-
rofilaria. Most of these tests (e.g. DirotectR,
DirokitR) have since been withdrawn from the
market. Their accuracy was extremely low, and
cross-reactivity to both D. reconditum and in-
testinal nematodes was very common. Re-
search showed values of 47% false positives,
and 30% false negatives.5 They did have some
value in detecting prepatent or immature infec-
tions, where antibody may be increased,and
antigen not yet detectable.
The newest ELISA available detects the
circulating adult Dirofilaria associated anti-
gen. These tests (e.g. FilarochekR, DirochekR,
CITETM ) are extremely sensitive, specific, and
accurate. Cross-reactivity is not a problem.
One trial showed only 4% false negatives, and
2% false positives.5 The test can be run on fresh
or frozen serum samples and shows 95% sensi-
tivity in animals with a burden of five or more
worms.3 This test has quickly become the sero-
logical test of choice. It shows positive results
as early as six months post infection, and twelve
weeks after effective adulticide treatment anti-
gen levels are nondetectable.3 The test is also
showing great promise as a prognostic indi-
cator. Two fold dilutions of the patients
serum with physiological saline can be used
to calculate a titer. This titer is used to predict
the relative worm burden and identify the dogs
with the greatest risk of pulmonary embolic
disease after adulticide treatment. This test
can also be used to detect circulating antigen in
the less common hosts ofD.immitis such as the




After establishing the presence of heart-
worm infection, treatment ofthe animal should
be strongly encouraged. Untreated animals
serve as a reservoir of infection for other ani-
mals. The treatment regime can be divided into
five steps:
1) Pretreatment Evaluation
2) Stabilization: Supportive /sympto-




Pretreatment evaluation: is important to
establish the health status ofan animal prior to
adulticide treatment. The recommended mini-
mum data base varies greatly from source to
source. Acornplete history and thorough physi-
cal exam are essential. The physical exam
should closely evaluate the cardiopulmonary
system. A CBC and serum chemistry profile
are recommended for older patients over five
years, as well as any showing clinical signs. A
urinalysis has also been advised. These latter
tests, although not predictive of possible com-
plications, establish the presence ofconcurrent
disease conditions. Thoracic radiographs are
strongly recommended for clinical cases. The
degree ofradiographic change has a direct rela-
tionship to the duration and severity of infec-
tion. Radiographs can provide a clinician with
valuable prognostic information.
Stabilization of the patient's condition prior
to the adulticide treatment is important, even if
treatment must be delayed for several weeks.
Animals may present with severe concurrent
disease conditions on the pretreatment evalu-
ation. These clinical signs may be a direct
result of advanced heartworm disease, or exist
as a separate entity.
Adulticide treatment can begin immediately
after stabilization of the patient. Two drugs
have been used as adulticides, levamisole and
thiacetarsemide. Levamisole is not approved
for this use, and is not dependable. Adult
female worms are very resistant to its effects.
Thiacetarsemide is the better choice for treat-
ment. Thiacetarsemide is approved for use as a
Dirofilaria adulticide. It is in no wayan ideal
drug. Experimentally, worm kills have been
around sixty-three percent; only forty percent
of the dogs treated were completely cleared of
adults. 1 The immature and female worms show
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some resistance to the drug. The treatment
protocol involves four intravenous injections at
intervals not less than 6-8 hours, or greater
than 15 hours. Care must be taken not to inject
the drug perivascularly or severe skin sloughs
can result. An injection of 2.2 mg/kg is given
BID for two consecutive days. The animal may
be usually hospitalized for 1-2 weeks following
treatment for observation.
Adverse reactions may be seen with adulti-
cide treatment. Toxic reactions to thiacetarsem-
ide occur infrequently. As an arsenical com-
pound, thiacetarsemide is excreted by the kid-
neys, gut, and liver. It can produce both hepa-
totoxicity and nephrotoxicity. Clinical signs
include vomiting, lethargy, anorexia and icterus.
Vomiting after the first dose is not uncommon
and usually can be controlled by feeding 30
minutes prior to the injections. If vomiting
persists, or other signs occur, treatment should
be aborted. After restabilization, the animal
can be retreated in 4-6 weeks. Toxic reactions
following the second treatment are rare. No
diagnostic test has been found which accu-
rately predicts acute toxicity. Liver enzyme
values are not predictive. 1 Liver sparing drugs
such as choline, methionine, or inisotol have no
value.8 One source indicated the presence of
bilirubinuria may be a clue to impending toxic-
ity, and should be evaluated before each injec-
tion.8 Aborting the treatment, and supportive
care is usually sufficient to correct the toxicosis.
Pulmonary thromboembolism occurs as a
sequelae of adulticide treatment. It occurs
most commonly 7-17 days post treatment, but
clinical signs of embolization been reported
from 5-30 days post adulticide. These signs
include cough, dyspnea, pulmonary crackles,
fever, and tachycardia. Animals showing ra-
diographic evidence of severe pulmonary par-
enchymal disease are more likely to experience
clinical signs of thromboembolism. If signs
occur, prednisone should be administered at a
dose of1-2 mg/kg until clinical and radiographic
signs have resolved. Corticosteroids should
only be used ifsigns ofthromboembolism occur.
They will decrease the efficacy ofthiacetarsem-
ide, and more seriously, may exacerbate the
degree of arterial disease and promote throm-
boembolism, periarterial fibrosis, and decreased
pulmonary blood flow. 9
Antibiotics, bronchodilators, and aspirin
may also be valuable as adjunct therapy for pul-
nl0nary throITLboembolism. Aspirin is used in
82
animals with radiographic evidence of severe
pulnl0nary arterial disease. It appears to block
the ongoing pathogenesis of endothelial dam-
age and permits partial regression of lesions in
the presence of adult heartworms.9 It should
not be used routinely for heartworm infected
animals. A dosage of7 mg/kg for 13 weeks prior
to adulticide treatment and 3-4 weeks following
treatment has been recommended.9 The ani-
mals should be observed closely for gastrointes-
tinal bleeding, and concurrent use ofcimetidine
or oral protectants is advisable.
Microfilaricide is given 4-6 weeks after the
completion of adulticide treatment. There are
several drugs available for use as effective
microfilaricides.
Dithiazanine is the only approved microfi-
laricide available. It is administered orally at a
dosage of 7-11 mg/kg for seven days. Ifmicrofi-
lariae appear on a recheck following treatment,
a dosage of1115 mg/kg is used for an additional
seven days ifno signs oftoxicity occur. Dithiaza-
nine is a cyanide dye. Toxic effects include
vonliting, diarrhea, and anorexia. Feeding a
meal prior to treatment may prevent vomiting.
Clients should be warned the vomitus and feces
from treated animals will stain fabrics.
Levamisole, although not approved, has been
used as a microfilaricide. Administered orally
at a dosage of 10-11 mg/kg, SID for 1-2 weeks,
it is as effective as dithiazanine.8 Animals should
be rechecked after one week of treatment. If
toxic signs such as vomiting, lethargy, stiffness,
or nervousness occur, treatment should be
stopped. Levamisole has a low margin ofsafety,
and the above dosage should not be exceeded.
Dividing the dosage into a BID treatment may
prevent vomiting, without altering efficacy.8
Ivermectin is the most recent introduction
to the microfilaricide line. Although not yet
approved for this use, it is very popular among
practitioners. One oral dose at 50 mcg/kg is
99.9% effective in clearing an animal. 8 If two
consecutive rechecks prove positive, surviving
adult worms should be suspected. Toxic reac-
tions to ivermectin are very rare, but occur
more frequently with high numbers ofmicrofi-
lariae.8 Collies have also shown an increased
sensitivity at this dose, presenting with an an-
aphylactoid reaction. Its use in this breed
should be avoided.
Prophylaxis should begin immediately af-
ter clearance of the microfilaremia if exposure
to infected mosquitoes is possible.
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Summary
Heartworm disease can be prevented. Pre-
vention is much safer and more effective for the
animal than treatment. Most prevention pro-
grams today make use of either diethylcar-
bamazine or ivermectin. Both of these drugs
are approved as preventatives, and are very
safe and nearly 100 percent effective if used
properly.
Prophylaxis should begin with the mosquito
season, and continue for two months after the
seasons end. In warm climates, prophylaxis
should be continued throughout the entire year.
Animals should be checked for heartworm in-
fection prior to beginning prophylaxis each year,
or every six months ifyear round prevention is
used. Testing is not necessary for animals less
than six months of age, since patency could nvt
yet be present. Pups can begin prevention
therapy at 6-9 weeks of age.
Diethylcarbanlazine (DEC) is administered
at a dosage of6.5 mg/kg orally on a daily basis.8
DEC can only be used in amicrofilaremic ani-
mals. Its use in microfilaria positive animals
may result in anaphylaxis, with DIC, shock,
and death in 5-20% of the reacting animals.8 If
an animal on DEC is discovered to be microfi-
laremic, the drug should be continued on a daily
basis during treatment. However, if no DEC
has been given for several days do not reinsti-
tute the therapy. Its use to prevent reinfection
during the treatment of occult disease is safe.
Side effects in amicrofilaremic dogs are very
rare. Vomiting may occur infrequently.
Ivermectin can be used at a dosage of6 mcg/
kg orally once a month.8 At this dosage it is an
effective preventative but not a microfilaricide.
Toxic reactions are very rare, even in the collie
breed at this dosage. It can be given to microfi-
laremic animal without adverse reactions. This
is a great advantage in animals where the
heartworm infection is asymptomatic, and age
or concurrent illness makes treatment a great
risk. The adult worms will die naturally, while
the aninlal is protected from reinfection. It is
important to remember that these animals are
still sources of infection.
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